Patents Assigned to KDX DIAGNOSTICS, INC.
  • KERATIN 17 AS A BIOMARKER FOR BLADDER CANCER
    Publication number: 20220412977
    Abstract: The current disclosure provides methods for detecting and analyzing K17 expression in a bladder sample obtained from a subject. The current disclosure also pertains to methods and kits for identifying a mammalian subject with bladder cancer by detecting the expression of K17 in a sample. The present methods include both cell-based and cell-free methods for determining the level of keratin 17 in a sample obtained from the bladder of a subject.
    Type: Application
    Filed: May 27, 2022
    Publication date: December 29, 2022
    Applicants: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, KDX DIAGNOSTICS, INC.
    Inventors: Kenneth R. SHROYER, Luisa F. ESCOBAR-HOYOS, Nam KIM
  • Keratin 17 as a biomarker for bladder cancer
    Patent number: 11360092
    Abstract: The current disclosure provides methods for detecting and analyzing K17 expression in a bladder sample obtained from a subject. The current disclosure also pertains to methods and kits for identifying a mammalian subject with bladder cancer by detecting the expression of K17 in a sample. The present methods include both cell-based and cell-free methods for determining the level of keratin 17 in a sample obtained from the bladder of a subject.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: June 14, 2022
    Assignees: The Research Foundation for The State University of New York, KDx Diagnostics, Inc.
    Inventors: Kenneth R. Shroyer, Luisa F. Escobar-Hoyos, Nam Kim
  • KERATIN 17 AS A BIOMARKER FOR BLADDER CANCER
    Publication number: 20200284794
    Abstract: The current disclosure provides methods for detecting and analyzing K17 expression in a bladder sample obtained from a subject. The current disclosure also pertains to methods and kits for identifying a mammalian subject with bladder cancer by detecting the expression of K17 in a sample. The present methods include both cell-based and cell-free methods for determining the level of keratin 17 in a sample obtained from the bladder of a subject.
    Type: Application
    Filed: August 4, 2017
    Publication date: September 10, 2020
    Applicants: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, KDX DIAGNOSTICS, INC.
    Inventors: Kenneth R. SHROYER, Luisa F. ESCOBAR-HOYOS, Nam KIM